Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
Investigating the impact of PGC-1a-coupled metabolic reprogramming on breast cancer metastasis
EF 2021-22
Résumé
An increasingly recognized feature of cancer is its ability to make alterations to metabolism to meet the high energy demands of rapidly growing tumours. The ability to reprogram their metabolism also helps cancer cells to better adapt to stressful conditions imposed by new environments, thereby supporting the movement of cancer cells from one site in the body to another in a process known as metastasis. Reprogrammed metabolism in cancer cells may further promote metastasis by contributing to the activation of cancer-associated fibroblasts at the tumour site, yielding a group of cells capable of releasing proteins and nutrients that promote cancer progression and that prime the tumour environment for cell migration. Cellular metabolism is controlled in part by peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC-1a), whose activity is associated with generating mitochondria and producing energy in the mitochondria. Interestingly, studies have demonstrated that increased PGC-1a expression in breast cancer cells increases their ability to metastasize to the lung in mice. However, the way in which PGC-1a-mediated changes to metabolism impacts breast cancer metastasis is unknown. The objective of this project will be to investigate how PGC-1a-mediated reprogramming of metabolism contributes to breast cancer metastasis. To achieve this objective, a combination of cell lines and mouse models of breast cancer will be used to identify PGC-1a-mediated metabolic alterations and how these changes impact breast cancer cell survival, division, and migration. Overall, gaining a better understanding of altered metabolism in breast cancer may allow us to uncover metabolic vulnerabilities that can be therapeutically targeted to better treat this widespread disease.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
467228
Name
Ciccolini Emma R
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the impact of PGC-1a-coupled metabolic reprogramming on breast cancer metastasis
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Breast Cancer Metastasis; Breast Cancer Metastasis To The Lung; Cancer Associated Fibroblasts; Cancer Metabolism; Metabolic Coupling; Metabolic Flexibility; Peroxisome Proliferator-Activated Receptor Gamma-1alpha
Abstract
An increasingly recognized feature of cancer is its ability to make alterations to metabolism to meet the high energy demands of rapidly growing tumours. The ability to reprogram their metabolism also helps cancer cells to better adapt to stressful conditions imposed by new environments, thereby supporting the movement of cancer cells from one site in the body to another in a process known as metastasis. Reprogrammed metabolism in cancer cells may further promote metastasis by contributing to the activation of cancer-associated fibroblasts at the tumour site, yielding a group of cells capable of releasing proteins and nutrients that promote cancer progression and that prime the tumour environment for cell migration. Cellular metabolism is controlled in part by peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC-1a), whose activity is associated with generating mitochondria and producing energy in the mitochondria. Interestingly, studies have demonstrated that increased PGC-1a expression in breast cancer cells increases their ability to metastasize to the lung in mice. However, the way in which PGC-1a-mediated changes to metabolism impacts breast cancer metastasis is unknown. The objective of this project will be to investigate how PGC-1a-mediated reprogramming of metabolism contributes to breast cancer metastasis. To achieve this objective, a combination of cell lines and mouse models of breast cancer will be used to identify PGC-1a-mediated metabolic alterations and how these changes impact breast cancer cell survival, division, and migration. Overall, gaining a better understanding of altered metabolism in breast cancer may allow us to uncover metabolic vulnerabilities that can be therapeutically targeted to better treat this widespread disease.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ciccolini, Emma R
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~